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A Case of Diode Laser Photocoagulation in the Treatment 
of Choroidal Metastasis of Breast Carcinoma
Sang Joon Lee, MD, Soo Young Kim, MD, Shin Dong Kim, MD
Department of Ophthalmology, College of Medicine, Kosin University, Pusan, Korea 
To report a single case of improvement on choroidal metastasis of breast cancer after laser photocoagulation. 
A 52-year-old female patient who complained of visual disturbance of the right eye with multiple states of 
metastasis of breast carcinoma. On initial examination, the right best-corrected visual acuity was 0.63. Right 
fundoscopy revealed an elevated mass-like lesion temporal to the macule with serous retinal detachment. 
The mass had a 3.5-disc diameter. A right fluorescein angiogram revealed hypofluorescence during the 
prearterial and arteriovenous phase and hyperfluorescence during the venous phase. The venous phase 
showed almost total masking of background choroidal fluorescence at the elevated lesion because of 
leakage and neovascularization. The patient was treated 4 times by diode laser photocoagulation in addition 
to chemotherapy. Fifty days after the diode laser treatments, the funduscopy examination and fluorescein 
angiogram revealed that the serous retinal detachment had been absorbed, the choroid had become flat, the 
lesion had been reduced in size and hyperfluorescence. The right best-corrected visual acuity was improved 
to 0.8. Laser photocoagulation appears not to cause any problems for the patient and may be an efficient 
treatment for patients with choroidal breast carcinoma. 
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Intraocular metastases are now considered the most 
common malignancy of the eye and occur in approximately 
2% to 7% of patients with cancer. Although any site of the 
eye can be affected by metastatic disease, the most common 
tissue involved is the choroid, possibly due to its high 
vascularization.
1 Breast cancer is the most common 
malignancy to metastasize to the uvea and accounts for 39% 
to 49% of all uveal metastases.
2 Conventionally, the treatment 
of choroidal metastasis may include radiotherapy, chemotherapy, 
observation, laser therapy, and surgical intervention. This 
paper presents a case of diode laser therapeutic regression of 
choroidal metastasis of breast carcinoma. 
 
Case Report
A 52-year-old woman sought treatment for decreased 
visual acuity of 1 month in the right eye. The patient was 
previously treated with radial mastectomy and chemotherapy 
5 years ago for an invasive ductal carcinoma of the right 
breast. Lung, liver, bone and brain metastases were found 1 
year previously. On initial examination, visual acuity with 
correction was 0.63/0.8 (OD/OS) and intraocular pressure 
(IOP) was 15/16 mmHg. Right fundoscopy revealed an 
elevated mass-like lesion at temporal to the macule with 
serous retinal detachment. The mass had a 3.5-disc diameter. 
No choroidal lesions were observed in the left fundus.A right 
fluorescein angiogram revealed hypofluorescence during the 
prearterial and arteriovenous phase and hyperfluorescence 
during the venous phase. The venous phase showed nearly 
complete masking of background choroidal fluorescence at the 
elevated lesion due to leakage and neovascularization (Fig. 1). 
Treatment was started with diode lasers while the patient 
was undergoing chemotherapy in hematology (gemzar-navelvin 
4th, taxotere-cis 3rd). The goal was to achieve white laser 
marks on the retina. The typical settings were as follows: 
intensity, 300-400 milliwatts; duration, 0.2 seconds; size, 
200-500 microns; 250-300 shot per serial. The patient 
underwent treatment with a diode laser once a week for a 
total of 4 weeks.
After 50 days, right funduscopy revealed mass regression 
in size and height and resolved retinal detachment. Right 
fluorescein angiogram revealed a flat devascularized choroid, 
The venous phase showed some leakages from the old lesion 
that affected the fovea (Fig. 2). Right visual acuity improved 
with a correction of 0.8.Korean J Ophthalmol Vol.22, No.3, 2008
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Fig. 1. (A) Right fundoscopy revealed an elevated mass-like 
lesion temporal to the macule with serous retinal detachment. 
The mass had a 3.5-disc diameter. (B) A right fluorescein 
angiogram revealed hypofluorescence during the prearterial and 
arteriovenous phase and hyperfluorescence during the venous 
phase. (C) A right fluorescein angiogram revealed hypofluo- 
rescence duringthe venous phase showing a nearly complete 
masking of background choroidal fluorescence at the elevated 
lesion due to leakage and neovascularization.
Fig. 2. After 50 days, (A) Right fundoscopy revealed mass 
regression in size and height and resolved retinal detachment. 
(B, C) A right fluorescein angiogram revealed flat devascularized 
choroids. The venous phase showed leakages from the old lesion 
that affected the fovea. 
For one month, the patient preserved the visual function 
and expired due to cancer emboli. 
C C
B B
A AJ Lee, et al. LASER THERAPY IN CHOROIDAL METASTASIS OF BREAST CA
189
Discussion
The various methods for treatment of choroidal metastasis 
areas follows: observation, radiotherapy, laser photocoagulation, 
transpupillary thermotherapy, chemotherapy, and enucleation.
3 
Radiotherapy is the preferred modality for local treatment of 
an ocular tumor. External beam radiotherapy has been the 
most commonly used treatment. Although shown to be very 
effective, 3 to 4 weeks of daily radiation treatment is 
necessary, which many patients with metastasis find daunting, 
considering the serious condition of their health.
4 Radiotherapy 
presents a risk for local complications such as cataracts, dry 
eye syndrome, and radiation retinopathy.
3,5  According to 
Halpern and colleagues,
6 chemotherapy alone is effective in 
approximately one third of the cases. However, systemic 
therapy has side effects such as gastrointestinal manifestation, 
fatigue, generalized weakness, neutropenia, or cardiotoxic 
effects.
7 
Laser photocoagulation yields a rapid response, is easy to 
perform on an outpatient basis, and is an effective therapy. 
Levinger and colleagues,
5 treated 10 eyes of 7 patients with 
krypton red or argon green laser applications for small 
choroidal breast carcinoma metastasis with serous detachment 
of the retina. In all eyes, the tumor decreased, the subretinal 
serous detachment was absorbed, the retina flattened, and the 
visual acuity improved without complications. The method by 
which the laser is effective in eradicating choroidal 
metastases is not clear. According to Levinger and 
colleagues,
5 the effectiveness of the laser treatment was not 
a result of occlusion of the retinal or choroidal blood 
circulation. A possible explanation for the mode of laser 
action is the destruction of the vasculature of the tumor. In 
other words, the laser closes all the blood vessels of the 
tumor, causing the tumor cells to die. Glaser and colleagues
8,9 
suggested that laser treatment may effect the retina and 
choroid through the release of extracellular modulating 
factors by laser-induced chorioretinal scars including 
neovascularization inhibiting factors. If this theory is correct, 
the laser may induce destruction of the metastatic tumor by 
inhibition of the tumor angiogenesis, and formation of 
ischemia.
5 
In this study, diode laser photocoagulation was selected 
because the patient's physical condition was poor and the 
laser procedure was short. Consequently, the mass regressed, 
subretinal serous detachment was absorbed, and the visual 
acuity improved. Laser photocoagulation does not appear to 
cause complications for the patient and may be an effective 
treatment for patients with choroidal metastasis of breast 
carcinoma. 
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